QURE
uniQure NV
NASDAQ · Healthcare · Biotechnology · NL
$22.20
+1.93%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 27.80x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.75x
- Price / sales
- 82.47x
- Price / cash flow
- -9.58x
Enterprise value
- Enterprise value
- $792.4M
- EV / sales
- 42.44x
- EV / EBITDA
- -4.38x
- EV / EBIT
- -3.90x
- Market cap
- $1.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026